Madison, WI, United States of America

Natalie Callander

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Lynx Biosciences, Inc.. Active years: 2018.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Natalie Callander

Introduction

Natalie Callander is a prominent inventor based in Madison, WI (US). She has made significant strides in the field of biomedical research, particularly in cancer treatment. Her work focuses on developing systems that enhance the understanding of patient-specific cancer therapies.

Latest Patents

Natalie holds a patent for "Cellular cis-co-culture systems for analysis." This invention relates to systems and methods for studying patient cancer samples in cis-co-culture with stromal cells from the same patient. The invention provides systems and methods for testing therapeutic agents in vitro in an environment that simulates an in vivo environment. This approach aims to identify agents that are therapeutically effective for the patient, thereby improving personalized medicine.

Career Highlights

Natalie is currently associated with Lynx Biosciences, Inc., where she continues to contribute to innovative research in cancer biology. Her work is pivotal in bridging the gap between laboratory research and clinical applications.

Collaborations

Natalie collaborates with talented individuals such as Chorom Pak and Edmond Wai Keung Young. These partnerships enhance the research efforts at Lynx Biosciences, Inc. and contribute to the advancement of cancer treatment methodologies.

Conclusion

Natalie Callander's innovative work in developing cellular systems for cancer analysis exemplifies her commitment to improving patient outcomes. Her contributions are vital in the ongoing quest for effective cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…